Amendments to the Patent Act, passed in 2018 to replace a prior clumsily worded provision enacted 25 years earlier, state that a patent or certificate of supplementary protection is not…
Category: Uncategorized
in Access to Medicines, Blogs, Commercialization, Development, Innovation, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
301
Broken Promises: Utility Standards and Patent Applications in Canada
The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was…
What’s Innovative About Cryptocurrency and Hayek’s “Free Market Money”? — Some Understated Obstacles in the Race for Blockchain Patents
If we are going to be fair, the cryptocurrency idea dates back to almost forty years ago. In an article published in the Wall Street Journal on August 19, 1977,…
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
268
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…
in Blogs, Cross Border Issues, Gaming, Infringement, Infringement, IP, Patent Trolls, Patentability, Patents, Technology, UK, Uncategorized, US0by Editor
183
Big Telecom versus Video Games: Big Implications
As reported on Kotaku.com – “British Telecommunications, a multinational mega-conglomerate with origins dating back to the 1800s, is suing Valve, a video game company that can’t count to three”. British Telecommunications…
Re Facebook Biometric Information Privacy Litigation
Canadian users of Facebook may be familiar with the process of “tagging” photos – adding the names of the people to images – but they may not be familiar with…